How to Start Donepezil
Start donepezil at 5 mg once daily in the evening, just prior to bedtime, and maintain this dose for 4 to 6 weeks before considering any dose increase. 1
Initial Dosing
- Starting dose: 5 mg once daily in the evening, just before retiring
- Timing: Evening administration is recommended (just prior to bedtime)
- Food: Can be taken with or without food 1
This starting regimen applies to all patients with Alzheimer's disease regardless of severity (mild, moderate, or severe) 1.
Titration Schedule
For Mild to Moderate Alzheimer's Disease:
- Maintain 5 mg daily for 4 to 6 weeks before considering dose escalation
- Maximum dose: 10 mg daily 1
- Do not increase to 10 mg until the patient has been on 5 mg for at least 4 to 6 weeks 1
For Moderate to Severe Alzheimer's Disease:
- Start with 5 mg daily for 4 to 6 weeks
- Then increase to 10 mg daily for at least 3 months
- Maximum dose: 23 mg daily (only after being on 10 mg for at least 3 months) 1
- The 23 mg tablet must not be split, crushed, or chewed 1
Critical Timing Considerations
The 4 to 6 week waiting period before dose escalation is essential. Studies demonstrate that rapid dose escalation significantly increases cholinergic gastrointestinal side effects, particularly nausea, diarrhea, and anorexia 1, 2. The evidence shows that dose titration before escalating to higher doses results in significantly fewer cases of nausea compared to direct escalation 2.
Common Pitfalls to Avoid
Escalating too quickly: The incidence of nausea is markedly greater with rapid dose increases (11.8% vs 3% when comparing rushed vs appropriate titration) 1
Not counseling about timing: Evening dosing minimizes daytime cholinergic side effects and can reduce insomnia complaints 3
Ignoring body weight: Lower body weight patients are at higher risk for adverse events, particularly with higher doses. Consider this when planning escalation to 23 mg 4
Splitting the 23 mg tablet: This formulation must be swallowed whole 1
Safety Monitoring
While donepezil has a favorable safety profile compared to older cholinesterase inhibitors (no hepatotoxicity monitoring required unlike tacrine) 5, 3, monitor for:
- Gastrointestinal effects: Nausea, diarrhea, vomiting, anorexia (most common during dose initiation) 1, 6
- Cardiac effects: Bradycardia or heart block due to vagotonic effects on cardiac conduction 1
- Weight loss: Particularly with higher doses 7
- Sleep disturbances: If insomnia occurs, consider switching to morning dosing 3
Evidence Quality
The FDA labeling 1 provides the highest quality guidance for dosing, supported by extensive clinical trial data showing that donepezil produces statistically significant improvements in cognition and global function, though the average cognitive improvements may not reach clinically important thresholds (≥4 points on ADAS-cog) 5. However, a subset of patients does achieve clinically meaningful improvement, and the drug demonstrates benefits in activities of daily living and global assessment measures 5.